Family Medicine · Schaumburg, IL
NPI
1992884084
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2201 W Schaumburg Rd Ste B
Schaumburg, IL, 60194
Phone (847) 885-8480
Groups this clinician bills Medicare through
Medicare paid, 2024
$341K
4,468 services
Medicare patients, 2024
793
Average age 73
Drug cost, 2024
$2.3M
38,045 prescriptions
Company payments, 2025
$936
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Afshan Hameeduddin was code 99309 (snf e&m), 1,062 times for 270 patients. In total Afshan Hameeduddin billed 4,468 services in 61 codes, and Medicare paid $341K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 1,062 | 270 | $84.58 | $90K |
| 99348 Home E&M - New and Established | Office | 698 | 247 | $57.98 | $40K |
| 99309 SNF E&M | Facility | 448 | 119 | $87.72 | $39K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 353 | 85 | $51.07 | $18K |
| 99214 Office E&M - Established | Office | 315 | 118 | $92.43 | $29K |
| 99232 Hospital E&M - Subsequent | Facility | 181 | 46 | $64.64 | $12K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 162 | 162 | $132.52 | $21K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 154 | 71 | $39.19 | $6,036 |
| 99349 Home E&M - New and Established | Office | 152 | 113 | $96.12 | $15K |
| 99213 Office E&M - Established | Office | 140 | 89 | $63.08 | $8,831 |
| 99308 SNF E&M | Office | 128 | 45 | $58.89 | $7,538 |
| 99310 SNF E&M | Office | 81 | 66 | $122.76 | $9,944 |
| 99306 SNF E&M | Office | 79 | 77 | $147.70 | $12K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 69 | 63 | $43.08 | $2,972 |
| 99306 SNF E&M | Facility | 50 | 47 | $147.97 | $7,399 |
By year: 2022 $636K for 5,954 services; 2023 $386K for 4,768 services; 2024 $341K for 4,468 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 31 | 20 | $16.22 | $503 |
| 87426 Immunoassay | 25 | 20 | $34.62 | $866 |
Medicare prescription drug claims, 2024
In 2024, the drug Afshan Hameeduddin prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,069 prescriptions and refills. In total Afshan Hameeduddin wrote 38,045 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,069 | 2,304 | 287 | $24K |
| Levothyroxine Sodium Generic | 1,888 | 2,066 | 230 | $21K |
| Omeprazole Generic | 1,236 | 1,342 | 163 | $12K |
| Furosemide Generic | 1,148 | 1,237 | 163 | $5,559 |
| Gabapentin Generic | 1,040 | 1,093 | 140 | $15K |
| Eliquis Apixaban | 1,038 | 1,046 | 117 | $366K |
| Amlodipine Besylate Generic | 1,037 | 1,163 | 176 | $6,772 |
| Pantoprazole Sodium Generic | 999 | 1,112 | 164 | $12K |
| Metoprolol Tartrate Generic | 833 | 888 | 126 | $6,349 |
| Metformin Hcl Generic | 743 | 874 | 116 | $5,617 |
| Lisinopril Generic | 715 | 804 | 105 | $5,166 |
| Metoprolol Succinate Generic | 710 | 820 | 94 | $14K |
| Potassium Chloride Generic | 702 | 741 | 107 | $28K |
| Losartan Potassium Generic | 674 | 829 | 114 | $6,856 |
| Carvedilol Generic | 655 | 758 | 98 | $5,490 |
Brand drugs: 4,393 claims; generic drugs: 33,378 claims; opioid claims: 202.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Afshan Hameeduddin $936 ($936 in general payments such as food, travel and fees) from 18 companies. The largest payer was Pfizer Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 11 | $172 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $99.17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $83.13 |
| Amgen Inc. AMGN | 4 | $76.3 |
| Abbvie Inc. ABBV | 3 | $75.51 |
| Noven Therapeutics, LLC | 3 | $60.48 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $52.29 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $45.72 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $45.54 |
| Lilly USA, LLC LLY | 2 | $35.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.